For years, cancer treatment was dominated by chemotherapy, radiation therapy, and stem
cell transplantation. New insights into genetic characteristics of leukemic cells have initiated …

Chimeric antigen receptor (CAR)-T-cell therapy is an innovative form of adoptive cell therapy
that has revolutionized the treatment of certain hematological malignancies, including B-cell …

A novel nonmyeloablative conditioning regimen was investigated in 44 patients with
hematologic malignancies. The median patient age was 41 years. Many of the patients had …

We report the outcome of reduced-intensity allogeneic progenitor cell transplantation
(alloPCT) for 188 patients with lymphoma from the Working Party Lymphoma of the …

Purpose We recently reported that children with acute leukemias who show increasing
mixed chimerism (MC) after allogeneic stem-cell transplantation have a significantly …

Purpose: Patients with advanced myeloid malig-nancies who experience relapse after
allogeneic bone marrow transplantation (BMT) have a poor prognosis. Long-term survival …

In patients treated with allogeneic stem cell transplantation (SCT) for malignant disease who
suffer from a relapse after the transplantation, the role of second allogeneic SCT is often …

Graft-versus-host disease in its acute (aGvHD) or chronic form (cGvHD) remains the most
important posttransplantation factor influencing outcome after allogeneic hematopoietic stem …

Previous studies have shown that children with acute myeloid leukemia (AML) who
developed mixed chimerism (MC) were at high risk for relapse after allogeneic stem-cell …

Allogeneic stem cell transplantation (SCT) represents a curative treatment option for patients
with leukemia and lymphoma. T lymphocytes contained in the allograft mediate a graft …